Ferring Pharmaceuticals

This study compared two different fertility drugs to see which one helps women produce more eggs during IVF treatment. It involved 301 women in China who were struggling with infertility. Researchers tested different starting doses of the drugs to measure the number of eggs retri…

This study tested the safety and effectiveness of a treatment called RBX2660 (REBYOTA®) when given during a colonoscopy. It involved 41 adults suffering from recurrent C. difficile infections, a serious and debilitating gut condition. The goal was to see if this new delivery meth…

This study followed 57 men with prostate cancer to check the long-term safety of a medication called degarelix. It was an extension of a previous trial, and patients received treatment for at least five years. The main goal was to monitor for any concerning changes in health, lik…

This study observed 145 adult patients who received REBYOTA, a treatment designed to prevent repeat C. difficile infections. Researchers tracked patients for 6 months after treatment to see if the infection returned and to monitor their health. The main goal was to see how many p…

This study looked at the safety of a drug called NOCDURNA, which is used to treat the need to urinate frequently at night. Researchers reviewed the existing medical records of over 1 million adults in Denmark, Sweden, and Germany who had used the drug. The goal was to check for a…

This study observed how a fertility drug called REKOVELLE® was used in everyday medical practice for women undergoing their first IVF treatment. Researchers tracked 201 women to see how doctors decided on doses, monitored safety, and what pregnancy outcomes resulted. The goal was…